Skip to main content

Stryker Corp(SYK-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Stryker's Triathlon Tritanium Baseplate marks a decade of positive patient impact

PR Newswire - Thu Sep 21, 2023

Over 1 million Triathlon Cementless Knees implanted globally

MAHWAH, N.J., Sept. 21, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's leading medical technology companies, continues its year of milestones celebration with the 10th anniversary of the Triathlon Tritanium baseplate. Since its introduction in 2013, Triathlon Cementless, which includes the Triathlon Tritanium Baseplate, has delivered a decade of positive patient impact, demonstrated impressive survivorship data and has become a trusted solution for surgeons across the globe.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe